U.S. Professional Services Stock News

Wondering if ABM Industries at around US$37.49 is pricing in too much pessimism or offering hidden value? This article walks through the key signals you need to weigh. The stock has moved only 0.3% over the last 7 days, but this comes after a 14.4% decline over the past month and an 18.9% decline over the last year, which may have changed how investors see its risk and return profile. Recent coverage has focused on ABM Industries as a long established facilities services provider, with...

With no fresh headline event driving the move, Air Lease (AL) is drawing attention as investors reassess its aircraft leasing model, recent share performance and the relationship between its current US$64.80 price and underlying fundamentals. See our latest analysis for Air Lease. The share price has been relatively steady in recent weeks, while the 1 year total shareholder return of 36.29% and 3 year total shareholder return of 73.40% suggest stronger longer term momentum at the current...

Fulton Financial (FULT) is drawing attention after recent trading saw the stock close at $19.68, with a 1-day return of negative 2.38% and a past-month return of negative 7.30%. See our latest analysis for Fulton Financial. That recent 2.38% 1 day share price decline sits against a mixed picture, with a modest 1.08% year to date share price return, a 13.92% 1 year total shareholder return, and 59.81% over three years. This suggests earlier momentum now looks more muted. If Fulton Financial’s...

Prologis (NYSE:PLD) has entered a US$1.6b joint venture with GIC to expand its build to suit logistics facilities platform in key U.S. markets. The partnership focuses on pre leased, custom designed logistics properties that aim to serve long term, mission critical supply chain needs. The joint venture introduces a different capital structure for Prologis’ development pipeline, with institutional backing from GIC. For investors tracking logistics real estate, Prologis is a central player,...

Monster Beverage (NasdaqGS:MNST) reported record quarterly revenue in its latest results. Fourth quarter net sales crossed US$2b for the first time in the company’s history. International operations, particularly in the EMEA region, were a key driver of the performance. Monster Beverage is a major player in the global energy drink market, with a portfolio that targets on the go consumers looking for functional beverages. The latest quarter puts the focus back on the underlying business...

Atmos Energy (NYSE:ATO) is facing a lawsuit after a gas main leak led to a catastrophic house explosion in a Lake Dallas neighborhood. The incident caused severe injuries and triggered an extended neighborhood evacuation while crews addressed the gas infrastructure issue. Plaintiffs allege Atmos Energy failed to properly maintain and monitor its gas system, raising questions about safety practices and risk controls. Atmos Energy, a regulated natural gas utility, sits at the center of...

Wondering if Monarch Casino & Resort at around US$93.98 is offering a fair price or asking too much for its chips on the table. The stock has seen a 2.6% decline over the last 7 days and is down 2.0% over the past month, yet it shows a 21.4% return over 1 year and 68.0% over 5 years, which can influence how investors think about both risk and opportunity. Recent attention on Monarch Casino & Resort has focused on its role within the broader hospitality and gaming space, with investors...

Setting Up The Valuation Picture For AXIS Capital Holdings AXIS Capital Holdings might be on your radar if you are asking whether the current share price lines up with the underlying value of the business, and this article is built to help you answer exactly that question. At a last close of US$98.91, the stock has seen a 0.7% return over the last 7 days, a 3.6% decline over 30 days, a 5.1% decline year to date, a 1.1% return over 1 year, and very large gains of 93.7% over 3 years and 122.0%...

Veritone (VERI) has drawn fresh attention after announcing a multi-year agreement with Oracle to move its AI solutions, including aiWARE, Veritone Data Refinery, and Veritone Data Marketplace, onto Oracle Cloud Infrastructure. See our latest analysis for Veritone. The Oracle agreement and recent product updates arrive after a steep reset in expectations, with the share price down 61.6% year to date and a 5 year total shareholder return decline of 92.5%, pointing to fading momentum as...

SELLAS Life Sciences Group (SLS) is drawing attention after releasing preclinical data on its CDK9 inhibitor SLS009 in acute myeloid leukemia and filing both a universal shelf registration and a US$150 million at-the-market equity offering. See our latest analysis for SELLAS Life Sciences Group. Those preclinical SLS009 data and the fresh shelf and at the market filing are landing after a sharp run, with the 1 year total shareholder return near 3x and a 52.09% 90 day share price return, even...

Karman Holdings Inc. recently reported past fourth-quarter 2025 results showing sales of US$134.49 million and net income of US$7.71 million, with full-year 2025 sales reaching US$471.50 million and net income of US$17.37 million. The company also raised its 2026 revenue outlook to US$715 million–US$730 million as its funded backlog moved beyond US$1 billion and recent acquisitions broadened its space and defense capabilities. Now, we’ll examine how the raised 2026 revenue guidance and...

On March 23, 2026, Healthpeak Properties, Inc. closed a new US$400,000,000 unsecured delayed-draw term loan facility maturing in March 2031, with interest set at SOFR plus 80 basis points and the facility undrawn at closing. The participation of major lenders such as BofA Securities, JPMorgan, and Wells Fargo Securities underscores lender confidence in Healthpeak’s balance sheet strength and financing flexibility. Next, we’ll examine how this new undrawn US$400,000,000 term loan facility...

Regency Centers (NasdaqGS:REG) has been removed from the FTSE All-World Index. The change affects the company’s presence in a widely followed global equity benchmark used by many index funds. For investors tracking NasdaqGS:REG, the index removal comes with the stock around $74.3 and a value score of 5. The shares show a 9.3% return year to date and 6.2% over the past year, with longer term returns of 37.2% over three years and 57.5% over five years. This type of index change can influence...

Wondering if BGC Group at US$9.40 is pricing in its true potential, or if the market is asking you to pay too much for the growth on offer? The stock has returned 0.1% over the last week and 5.1% year to date, with a 3.3% return over the past year and very large gains over the last 3 and 5 years that set the backdrop for any valuation check today. Recent coverage around BGC Group has kept attention on how the business is positioned within capital markets and how it responds to changing...

Advance Auto Parts renewed its partnership with Team Penske and NASCAR Cup Series champion Ryan Blaney for upcoming NASCAR seasons. The agreement keeps Advance Auto Parts branding on the No. 12 Ford Mustang and at key NASCAR events. The deal includes planned in store appearances and fan engagement events featuring Ryan Blaney. For investors watching NYSE:AAP, this renewed motorsports partnership comes with the stock trading at $51.57. Shares are up 9.6% over the past week, 32.6% year to...

If you are wondering whether IDEX at around US$186.55 is offering fair value or a potential mispricing, you are not alone. The stock has returned 1.3% over the last 7 days, 4.2% year to date and 4.7% over the past year, but this sits alongside a 9.5% decline over the last 30 days and negative 3 and 5 year returns. These mixed returns have kept attention on IDEX, with investors weighing up how its business profile and industry position compare with current expectations. Recent coverage has...

In early March 2026, Capital Clean Energy Carriers Corp. reported a 36.5% year-on-year rise in Q4 2025 net income, took delivery of its first LCO2/multi-gas carrier Active funded partly by a 12-year ECA-backed loan, and completed the profitable sale of the M/V Buenaventura Express to lower debt. Together, the earnings jump, fleet upgrade into specialized multi-gas capacity, and balance sheet improvement offer a clearer view of how the company is aligning growth with capital discipline. We...

Tractor Supply, NasdaqGS:TSCO, is marking the 10th anniversary of its Country Mile recognition program. The company is honoring a record 20 team members for their contributions under the program. More than 750,000 recognition badges were awarded to team members over the past year. Tractor Supply, trading at $44.87, has seen a 38.1% return over the past 5 years, while the past 1 year reflects a 14.6% decline. Shorter term performance has also been softer, with returns of a 2.0% decline over...

How Distribution Solutions Group's recent share price sets up a valuation check Before getting into detailed valuation work, it helps to understand how Distribution Solutions Group's share price has been behaving and what recent information is shaping expectations. Over the last week, the stock has been relatively steady with a 0.2% decline, but the past month has seen a sharper 12.6% pullback and the year to date return sits at a 7.2% loss, with the last 12 months at a 6.8% loss, even though...

Legence (LGN) has just posted another busy quarter, with Q3 FY 2025 revenue of US$708.0 million and a small loss, as Basic EPS landed at a US$0.02 loss and net income excluding extra items was a US$1.1 million loss. The company has seen revenue move from US$560.8 million in Q3 FY 2024 to US$708.0 million in Q3 FY 2025. Over the trailing 12 months, revenue reached about US$2.4 billion against a trailing 12 month net loss of US$19.8 million, putting the spotlight squarely on scaling margins...

Structure Therapeutics (NasdaqGM:GPCR) released highly positive Phase 2 topline data for its oral GLP-1 receptor agonist aleniglipron in obesity and overweight patients. The new results from the ACCESS clinical program show significant weight loss, a compelling safety and tolerability profile, and low discontinuation rates. The company plans to advance aleniglipron into Phase 3 trials based on these Phase 2 outcomes. Structure Therapeutics focuses on small molecule medicines, and...

If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in. The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years. Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader...

Zentalis Pharmaceuticals (ZNTL) has just posted its FY 2025 first half results with total revenue at US$0 million, basic EPS at a loss of US$1.05, and net income excluding extraordinary items at a loss of US$75.2 million. This puts the focus firmly on expense control and cash burn. Over the recent periods, the company has seen revenue move from US$40.6 million in the first half of 2024 to US$26.9 million in the second half of 2024, before dropping to zero in the latest half. Half year basic...

JBS (NYSE:JBS) has been removed from the FTSE All-World Index. The change affects the company’s presence in a major global equity benchmark tracked by many passive funds. The decision may influence how both current and prospective shareholders assess JBS within global portfolios. JBS, trading at $17.03, has seen a return of 19.5% over the past week and 20.1% year to date, with a 3.8% return over the past 30 days. With a value score of 6, the stock sits in a segment of the market that some...